Escolar Documentos
Profissional Documentos
Cultura Documentos
doi: 10.1111/j.1528-1167.2011.03041.x
SUMMARY
The etiology of epilepsy is a major determinant of clinical
course and prognosis, yet the current classifications of
epilepsy do not list etiology in any detail. In this article, a
classification (database) of the etiologies of epilepsy is
proposed. In this scheme, the etiology of epilepsy is
divided into four categories: idiopathic, symptomatic,
provoked, and cryptogenic. These are defined and subcategories are proposed. A commentary addressing the
1052
1053
Etiologic Classification of Epilepsy
resonance imaging (MRI) had been invented before
EEG.
Commentary
Problems with assigning causation
There are a number of factors that complicate the assignment of cause, and these are often overlooked. These will
have an impact on any attempt to classify epilepsies according to cause:
1. Multifactorial cause of epilepsy: As has been frequently
reiterated, epilepsy is in the great majority of cases multifactorial. In any individual case, the epilepsy is often
(perhaps almost always) the result of both genetic and
acquired influences and also influenced by provoking
factors (and many epilepsies clearly have both exciting
and predisposing causes, to reintroduce an old concept).
Assignment of such cases to any single etiology is, therefore, to an extent arbitrary. However, in most cases, there
is a predominant cause to which the case is assigned. In
clinical practice there are many obvious reasons why
such assignment of predominant cause is necessary and
valuable.
2. Cause versus mechanism: Hughlings Jackson urged that
the cause of epilepsy be considered to be mechanism of
ictogenesis or epileptogenesis, and not the more downstream underlying condition leading to the epilepsy (see
Taylor, 1930). He viewed most seizures to have a similar
final common pathway, regardless of causative lesion. In
the genetic epilepsies, we are currently closer to defining
cause by molecular mechanism, but in most symptomatic
epilepsies, the mechanisms of ictogenesis are largely
obscure. If knowledge was more complete, categorization of cause according to mechanism would be the optimal approach, and indeed should be at the heart of any
classification scheme. This issue should be a major focus
of future research but currently a list of downstream
causes remains necessary.
3. Cause depends on degree of investigation: The identification of cause is of course highly dependent on investiEpilepsia, 52(6):10521057, 2011
doi: 10.1111/j.1528-1167.2011.03041.x
1054
S. D. Shorvon
Table 1. Suggested scheme for an etiological classification of epilepsy
Main category
Subcategory
Examplesa
Idiopathic epilepsy
Neurocutaneous syndromes
Other neurologic single gene disorders
Predominately acquired
causation
Hippocampal sclerosis
Perinatal and infantile causes
Cerebral trauma
Cerebral tumor
Cerebral infection
Cerebrovascular disorders
Cerebral immunologic disorders
Provoked epilepsy
Reflex epilepsies
Cryptogenic epilepsiesb
DNET, dysembryoplastic neuroepithelial tumor.
a
These examples are not comprehensive, and in every category there are other causes.
b
By definition, the causes of the cryptogenic epilepsies are unknown. However, these are an important category, accounting for at least 40% of epilepsies
encountered in adult practice and a lesser proportion in pediatric practice.
This list is derived from the book Causes of Epilepsy (Shorvon et al., 2011b).
1055
Etiologic Classification of Epilepsy
This latter term was previously used to denote any epilepsy
in which there was no demonstrable cause, but now is used
only for those epilepsies that are primarily genetic in origin
and in which there is no gross neuroanatomic or neuropathologic abnormality.
In the framework proposed in this article, genetic conditions that result in either pathologic or anatomic change (for
instance, the epilepsy due to tuberous sclerosis or neurofibromatosis), or more subtle changes at the molecular pathologic level (for examples the epilepsies due to Rett
syndrome, CDKL5, Angelman syndrome) are included in
the symptomatic category. Also included are epilepsies due
to developmental abnormalities where there are neuropathologic changes, despite the fact that these are due to aberrant
development (and are sometimes largely genetic) rather
than to an external acquired cause. These developmental/
congenital disorders are a gray area between core idiopathic and core acquired epilepsies.
Of course this definition is open to criticisms on a number
of fronts. The idiopathic epilepsies may have subtle anatomic abnormalities, or synaptic, membrane, neurotransmitter, or network changes. The distinction from symptomatic
epilepsy, based as it is on the absence of a gross lesion
(defined above as any identifiable pathologic or anatomic
abnormality that can be detected in normal clinical investigation, including clinical microscopy, histology, and neurochemistry) is to an extent, therefore, arbitrary.
In the most recent ILAE Classification Commission
report, it was suggested that the terms idiopathic, symptomatic, and cryptogenic are replaced by the terms genetic,
structural/metabolic, and unknown. This suggestion has not
been followed here, for a number of reasons. Firstly, the
term idiopathic has been honored in history and should be
replaced only if there are major advantages to doing so, and
there is widespread disagreement about the need for this
change (see for instance Ferrie, 2010; Guerrini, 2010; Wolf,
2010). Furthermore, the idiopathic epilepsies are due in all
likelihood to a combination of genetic and environmental
influences (epistatic and epigenetic influences, particularly
in development), and although genetic influences probably
predominate, these have proved largely conjectural. There
are also many genetic causes of symptomatic epilepsy.
For these reasons, the term idiopathic seems worthy of
retention. Similarly, replacing the term symptomatic by
structural/metabolic also seems largely unnecessary, not
the least because many of the symptomatic conditions are
neither structural nor metabolic, in the normal sense of these
words. Replacing the term cryptogenic epilepsy with
epilepsy of unknown cause seems also simply to anglicize
and remove the venerable Greek origin to the word, rather
than to change the conceptual basis in any meaningful way.
Provoked epilepsy
This category is included in this database, and it is
not found in the recent commission report. In any etiologic
1056
S. D. Shorvon
as fever, metabolic disturbance, alcohol, and (2) acute brain
injury, which are best included as symptomatic causes. It
is senseless to include both types of causes within one category, as they are wholly different in terms of physiology and
clinical features. If the term is to survive it should be
restricted to the early seizures in acute brain injury
(trauma, stroke, etc.), which clearly have a different pathophysiology and prognosis compared to the later seizures
induced by these conditions (Shorvon & Guerrini, 2010).
Risk factor analysis
The most precise approach to the assignment of etiology
is to take a statistical route and to compare the frequency of
an etiologic factor in the epilepsy population (preferably at
the time of diagnosis) with that in a control population (of
the same demographic and geographic constitution). This
has seldom been attempted, although the reverse studya
case control study to define the frequency of epilepsy within
a defined etiologyhas been more commonly performed,
for instance in head injury, stroke, and some infections. In a
case control study, the following conditions should be met
(as noted by Beghi, 2004): (1) temporal associationexposure to the risk factor should precede epilepsy; (2) strength
of the associationthe greater the difference in incidence
between exposed and unexposed populations, the more
likely is this to be a true association; (3) consistencythe
association should be reproducible; (4) biologic gradientevidence of a doseresponse effect; and (5) biologic
plausibility.
Genetic and developmental mechanisms
The recent advances in genetics have made limited
inroads into understanding the genetic basis of epilepsy. The
most impressive findings have been made in relation to the
symptomatic epilepsies of metabolic origin, and the defective gene causing almost all of the single-gene metabolic
neurologic disorders has now been identified. Fifteen genes
have also been identified coding for pure epilepsies, but
despite intensive efforts, the genetic bases of the great
majority of idiopathic epilepsies remain largely obscure.
The reason is likely to be that idiopathic epilepsy is caused
by more complex genetic or developmental processes, and
large epistatic and epigenetic influences will be present. The
current emphasis on finding causal single nucleotide polymorphisms (SNPs) seems naive, and untangling the epigenetic and epistatic mechanisms will pose a formidable
challenge, yet these mechanisms probably hold the key to
the missing heritability of epilepsy. Other genetic
approaches may also help, and these include studies of such
mechanisms as copy number variation, genomic imprinting,
chromosomal imbalance, X inactivation, and mitochondrial
mechanisms. How the category of idiopathic epilepsy will
appear in the future after these further research efforts have
come to fruition is unclear. It should also be noted that many
genetic influences are not all or none but confer
Epilepsia, 52(6):10521057, 2011
doi: 10.1111/j.1528-1167.2011.03041.x
Acknowledgment
The classification scheme proposed here is based on the framework proposed in the Causes of Epilepsy (Shorvon et al., 2011b), and the commentary on several chapters from this book (Shorvon, 2011b,c; Shorvon et al.,
2011a).
Disclosure
I have no conflicts of interest to declare. This work was undertaken at
UCL and received a proportion of funding from the Department of Healths
NIHR Biomedical Research Centres funding scheme. I confirm that I have
read the Journals position on issues involved in ethical publication and
affirm that this report is consistent with those guidelines.
References
Aird RB. (1983) The importance of seizure-inducing factors in the control
of refractory forms of epilepsy. Epilepsia 24:567583.
1057
Etiologic Classification of Epilepsy
Beghi E. (2004) Etiology of epilepsy. In Shorvon SD, Perucca E, Engel J
(Eds) The treatment of epilepsy. 2nd ed. Blackwell Science, Oxford, pp.
5064.
Berg A, Berkovic S, Brodie M, Buchhalter J, Cross J, van Emde
Boas W, Engel J, French J, Glauser T, Mathern G, Mosh S,
Nordli D, Plouin P, Scheffer I. (2010) Revised terminology and
concepts for organization of seizures and epilepsies: report of the ILAE
Commission on Classification and Terminology, 20052009. Epilepsia
51:676685.
Commission on Classification and Terminology of the International League
Against Epilepsy. (1981) Proposal for revised clinical and electrographic classification of epileptic seizures. Epilepsia 22:489501.
Commission on Classification and Terminology of the International League
Against Epilepsy. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389399.
Engel J. (2001) A proposed diagnostic scheme for people with epileptic
seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42:796803.
Ferrie CD. (2010) Terminology and organiszation of seizures and epilepsies: radical changes not justified by new evidence. Epilepsia 51:713
714.
Gastaut H. (1969) Clinical and electroencephalographical classification of
epileptic seizures. Epilepsia 10(suppl):213.
Guerrini R. (2010) Classification concepts and terminology: is clinical
description assertive and laboratory testing objective? Epilepsia
51:718720.